Welcome to our dedicated page for Piper Sandler Co`S news (Ticker: PIPR), a resource for investors and traders seeking the latest updates and insights on Piper Sandler Co`S stock.
Piper Sandler Companies reports news on its investment banking and institutional securities business, including advisory services, equity and debt capital markets, public finance, institutional brokerage, research, fixed income, and alternative asset management activities. Coverage commonly includes financial results, dividends, capital actions, and updates to teams serving corporate, private equity, public entity, nonprofit, and institutional investor clients.
Company announcements also cover platform expansion in areas such as distressed debt, special assets, healthcare investment banking, life sciences outsourcing, B2B med tech, and fixed income. Governance-related news includes board appointments and other corporate updates tied to the firm’s public-company structure.
Piper Sandler (NYSE: PIPR) announced it has released its second quarter 2026 financial results, available at pipersandler.com/earnings, and declared a quarterly dividend of $0.20 per share. The company will host an earnings conference call on Thursday, July 30, 2026 at 8:00 a.m. CT, with U.S. dial-in 800-330-6710, international dial-in +1-312-471-1353, and passcode 8969597. A replay will be accessible on the earnings website approximately three hours after the call.
Piper Sandler (NYSE: PIPR) will release its second quarter 2026 financial results before market open on Thursday, July 30, 2026, via its website. Management will host a conference call at 9:00 a.m. ET (8:00 a.m. CT) with Q&A, accessible by phone and live webcast.
Piper Sandler (NYSE:PIPR) appointed John D’Amico as managing director in its restructuring group, based in New York. He will advise clients on complex restructurings and special situations, drawing on approximately 25 years of investment banking and corporate advisory experience across Chapter 11, out-of-court restructurings, M&A and financing.
CereVasc completed an over-subscribed $85 million Series C financing led by Piper Sandler Merchant Banking (NYSE:PIPR), with participation from JJDC, Medtronic, Bain Capital Life Sciences and Perceptive Xontogeny funds.
Funds support the STRIDE pivotal trial of the eShunt System, PMA work, operational scale-up, commercialization, and board expansion.
Piper Sandler (NYSE:PIPR) appointed Rob Parker and Tripp Griffin as co-heads of services and industrials investment banking. Former co-heads Matt Sznewajs and John Tye become vice chairmen of investment banking and, with David Lee, co-head the new private equity advisory effort.
This team will focus on expanding private equity business, which represents roughly half of advisory revenue.
Piper Sandler (NYSE:PIPR) is launching a distressed debt and special asset group within its fixed income platform, led by new managing directors John Mori (Greenwich) and Eric Friel (New York).
The group will source and trade specialized credit products and work closely with investment banking, capital markets and restructuring teams.
Mori and Friel join from Oppenheimer, bringing extensive distressed and high-yield experience.
Piper Sandler Companies (NYSE: PIPR) announced first-quarter 2026 results and scheduled an earnings conference call on May 1, 2026 at 7:30 a.m. CT. Investors can access the call by phone or via a live webcast; an audio playback will be available on the company website approximately three hours after the event.
Dial-in numbers and passcode are provided for U.S. and international participants, and the full earnings release is available at pipersandler.com/earnings.
Piper Sandler (NYSE: PIPR) announced the hiring of Patrick McCormack, M.D. as managing director in its healthcare investment banking group, based in San Francisco. McCormack will advise biopharma companies on mergers, acquisitions, and capital-raising transactions and joins from Wells Fargo Securities.
McCormack brings medical and MBA credentials and prior senior roles at Goldman Sachs, SVB Leerink, and SunTrust Robinson Humphrey.
Piper Sandler (NYSE: PIPR) will release first quarter 2026 financial results before market open on Friday, May 1, 2026. A conference call with CEO Chad Abraham, President Deb Schoneman, and CFO Kate Clune will follow at 8:30 a.m. ET to review results and take questions.
Investors can join via dial-in (800 330-6710 U.S.; +1 312 471-1353 international), passcode 5642050, or a live audio webcast and replay at pipersandler.com/earnings. Dial in at least 15 minutes early; replay and investor relations email are provided for access questions.
Piper Sandler (NYSE: PIPR) appointed Aamer Naseer as global head of life sciences outsourcing and B2B med tech, effective immediately as announced February 25, 2026.
Naseer brings 25 years of sector experience advising public and private medical device, manufacturing and outsourcing clients, positioned to expand the firm’s capabilities in life sciences outsourcing and B2B med tech.